about
The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activityUrokinase, a constitutive component of the inflamed synovial fluid, induces arthritisPhysical determinants of fibrinolysis in single fibrin fibersOrganization, evolution and functions of the human and mouse Ly6/uPAR family genesEffects of Kaixinjieyu, a Chinese herbal medicine preparation, on neurovascular unit dysfunction in rats with vascular depressionJugular thrombophlebitis in horses: a review of fibrinolysis, thrombus formation, and clinical managementCharacterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells.Molecular mediators of angiogenesis.Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors.Synergy between a plasminogen cascade and MMP-9 in autoimmune diseaseNew insights into the role of Plg-RKT in macrophage recruitment.Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment.Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice.A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptidesImmunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report.Protease nexin-1 expression is altered in human breast cancer.Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sitesThe plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritisTargeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death.Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice.Annexin A2 promotes glioma cell invasion and tumor progressionMembrane associated proteases and their inhibitors in tumour angiogenesis.Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.Conserved Amblyomma americanum tick Serpin19, an inhibitor of blood clotting factors Xa and XIa, trypsin and plasmin, has anti-haemostatic functions.Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndromeHomocysteine has anti-inflammatory properties in a hypercholesterolemic rat model in vivoCleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor.Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domains.The plasminogen activator system modulates sympathetic nerve function.Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.Blood markers of fibrinolysis and endothelial activation in canine babesiosisCHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity.The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease.Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients.Age-dependent increase in desmosterol restores DRM formation and membrane-related functions in cholesterol-free DHCR24-/- mice.Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior.Does plasmin have anticoagulant activity?Beta-amyloidolysis and glutathione in Alzheimer's disease.
P2860
Q24298078-3220CE88-A064-46A0-B028-C3BB30FC9FA8Q24795914-1F83B19A-F887-4A1F-AD1E-C201A6B5C82CQ27317618-CAD39F7F-7DFD-425F-A9B0-EC2638006E60Q28071700-104F161C-6FFA-41A1-B8D2-E3A7A5E04DFBQ28564382-EC21E866-F76A-46A0-8133-8D1350801154Q30452826-FECAF21E-3D0A-455A-B2B9-092A46A98E73Q33488055-06854594-D81E-470A-BB1F-7008E76B0D2FQ33639474-A7E94E76-C9B5-49B1-A555-EC3832689F6EQ33722964-5CCC530E-024C-49E6-8CFA-7044E9DB28A0Q33726930-8FD31DE8-C0D7-4C9A-9D0F-56058DD53BDBQ33768031-9E00EE66-88C3-42D1-906F-F79E9EE3F793Q33812093-0DC755C3-F916-4E5F-A230-84B631D4BB07Q34024041-41B948DD-FE07-4827-867B-9D06250F7AE3Q34434420-51D96E8E-3C9E-43CC-A52B-C33BB0B59969Q34494535-7B9070CA-10E3-45DD-9648-1A5B65FA560CQ34768102-607932A4-2E63-4924-A495-1EE4D94E3BC8Q35010889-856B731D-F81C-4EFD-BCFE-D3A5173393DDQ35083758-C8993887-8441-4099-8202-5A8644F38A84Q35107897-30E5D103-5309-4E62-80C3-B3F71E041407Q35130515-BEB6744B-0E2C-4985-8E14-07CCA664B6F4Q35448499-ADC6A6E2-D796-4319-A113-A668C801F461Q35587684-6B1212D6-651F-4361-9E7F-F5792D335F6BQ35721585-5B612E26-56ED-4460-A2AD-F78DB4BD247FQ35812375-E9210A57-0F7E-479B-B5FF-7BF0FBD8672CQ35878747-7C93E1A7-CC04-4126-8937-1BE258817F05Q35945520-A231A86D-31B8-4EF1-B60A-C1ECC1955061Q35985536-834EF87E-6D0B-4553-83A0-8BC36659882DQ36127093-8326F396-8891-4135-8AC1-8D78B5CA99FAQ36201781-342CACE6-0F65-4196-8E2F-9598A0474AACQ36228900-0B372317-074F-4E01-8E7D-126EB5B56C9EQ36302249-0C911D49-18B5-4276-81E5-39126FB45FBEQ36330442-792C4FAE-A56E-468F-9232-A01BB71F50B3Q36951765-7A84F840-0639-4360-93A3-3F11F7E96735Q36980771-5CC63F84-2163-445F-93D8-2549147BF56BQ37277958-15EE2AC2-735E-4A25-B473-E51C2012BD74Q37378740-600EFB3E-86FB-42CF-BFDD-F3DF67C2E82DQ37603401-810FCC2C-467A-43CE-A7C2-CF6DD21B519CQ37621854-C126D964-F88B-4164-B7C6-F8A96E2A5D3DQ37734885-7DD4916E-E88D-420B-9577-3A6FEDFB614AQ38104717-D9756150-3CAA-40F8-9793-09551575962C
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The plasminogen (fibrinolytic) system.
@ast
The plasminogen (fibrinolytic) system.
@en
type
label
The plasminogen (fibrinolytic) system.
@ast
The plasminogen (fibrinolytic) system.
@en
prefLabel
The plasminogen (fibrinolytic) system.
@ast
The plasminogen (fibrinolytic) system.
@en
P1476
The plasminogen (fibrinolytic) system.
@en
P2093
P304
P577
1999-08-01T00:00:00Z